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Background: The stabilizing and function-preserving effects of ectoines have attracted considerable
biotechnological interest up to industrial scale processes for their production. These rely on the release of
ectoines from high-salinity-cultivated microbial producer cells upon an osmotic down-shock in rather complex
processor configurations. There is growing interest in uncoupling the production of ectoines from the typical
conditions required for their synthesis, and instead design strains that naturally release ectoines into the medium
without the need for osmotic changes, since the use of high-salinity media in the fermentation process imposes
notable constraints on the costs, design, and durability of fermenter systems.
Results: Here, we used a Corynebacterium glutamicum strain as a cellular chassis to establish a microbial cell
factory for the biotechnological production of ectoines. The implementation of a mutant aspartokinase enzyme
ensured efficient supply of L-aspartate-beta-semialdehyde, the precursor for ectoine biosynthesis. We further
engineered the genome of the basic C. glutamicum strain by integrating a codon-optimized synthetic ectABCD
gene cluster under expressional control of the strong and constitutive C. glutamicum tuf promoter. The resulting
recombinant strain produced ectoine and excreted it into the medium; however, lysine was still found as a
by-product. Subsequent inactivation of the L-lysine exporter prevented the undesired excretion of lysine while
ectoine was still exported. Using the streamlined cell factory, a fed-batch process was established that allowed
the production of ectoine with an overall productivity of 6.7 g L-1 day-1 under growth conditions that did not rely
on the use of high-salinity media.
Conclusions: The present study describes the construction of a stable microbial cell factory for recombinant
production of ectoine. We successfully applied metabolic engineering strategies to optimize its synthetic
production in the industrial workhorse C. glutamicum and thereby paved the way for further improvements in
ectoine yield and biotechnological process optimization.
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Many microorganisms counteract the detrimental effects
of high salinity and high osmolarity through the accumu-
lation of water-attracting organic osmolytes, the so-called
compatible solutes [1-3]. The term “chemical chaperone”
has been coined in the literature to characterize the cellu-
lar functions of these compounds as stabilizers of macro-
molecules [4-6]. Among them, the tetrahydropyrimidines
ectoine and 5-hydroxyectoine have been most widely
adopted in practical applications, and their biotechno-
logical production has been advanced to an industrial
scale [7,8]. Ectoines possess excellent stabilizing effects on
biological molecules; e.g. proteins, cell membranes, DNA,
and even entire cells. They safeguard proteins against ag-
gregation, promote their proper folding under otherwise
denaturing conditions, and they are fully compliant with
cellular physiology, biochemistry and protein functions
[9-12]. Related to these attractive properties, industry has
merchandized ectoines as protective compounds for
health care products and cosmetics [7,13,14]. To some
extent they also find application as in vivo folding catalyst
for the recombinant production of proteins [15] and as
enhancers for polymerase chain reactions [16]. The anti-
inflammatory effect of ectoine even suggests a medical
oriented application in the future for treating lung inflam-
mation [17] and colitis [18], and for tissue protection in
ischemia [19]. Although the chemical synthesis of ectoines
is certainly possible [16], their large-scale production with
a high degree of purity and stereo-specificity is compli-
cated and costly. Chemical synthesis was consequently
outcompeted by a biotechnological production route
using the halophilic bacterium Halomonas elongata [20].
In vivo, ectoine is synthesized from the precursor L-
aspartate-β-semialdehyde (ASA), a central hub in micro-
bial amino acid production [21], by three successive
enzymatic steps that are catalyzed by the L-2,4-diamino-
butyrate transaminase (EctB), the 2,4-diaminobutyrate
acetyltransferase (EctA) and the ectoine synthase (EctC)
[22,23] (Figure 1A). A substantial subgroup of the ectoine
producers can convert ectoine into 5-hydroxyectoine
through the activity of the ectoine hydroxylase (EctD)
[24,25] (Figure 1A). The ectoine biosynthetic genes are
normally organized in an operon (ectABC) [23,26-28] that
might also comprise the ectD gene [24,29,30]. Expression
is typically induced in response to increased osmolarity
[8,26,27,31] or extremes in growth temperature [27,31].
Transcriptional profiling indicated that the cellular levels
of ASA could be a potential bottleneck in the synthesis of
ectoines [32]. Some natural producers can avert this
through the co-production of an aspartokinase (Ask_Ect)
with special biochemical features [33].
The industrial ectoine production process - popularly
referred to as “bacterial milking” - entails the fermentation
of H. elongata under high-salinity growth conditions anda subsequent rapid osmotic downshift to release the
produced ectoine from the cells through the transient
opening of mechanosensitive channels [34,35]. While the
bacterial milking procedure is an expedient way to recover
ectoine under industrial settings [7,8,20], concerted efforts
have recently been made to enhance the efficiency and
convenience of its production. These efforts include the
use of mutants of H. elongata that hyper-secrete ectoine
[36], alternative microbial production strains [33,37-39],
modifications of the fermentation and milking procedures
[38-42], and attempts to raise production through recom-
binant DNA techniques employing both pro- and eukar-
yotic host systems [33,37,43-45]. In particular, attempts
are being made to uncouple ectoine production from high
osmolarity since the use of high-salinity media in the
fermentation process imposes notable constraints on the
costs, design, and durability of fermenter systems.
We considered the non-pathogenic Gram-positive soil
bacterium Corynebacterium glutamicum, a well-estab-
lished industrial workhorse [46], as an excellent candidate
for the development of a synthetic production platform of
ectoines. Owing to the wide use of C. glutamicum in
biotechnology, in-depth knowledge on its large-scale
fermentation as well as genetic tools are available to
metabolically direct and streamline the production of
commercially interesting metabolites [47-50]. Keeping in
mind that the synthesis of ectoine proceeds from ASA
(Figure 1A), C. glutamicum seemed to be a particular well
suitable chassis, as biotechnological manufacturing of L-
lysine has bred feedback-resistant aspartokinase enzymes
[51]. As C. glutamicum is not a natural ectoine/hydro-
xyectoine producer [52], we designed a synthetic cell
factory recruiting the ectABCD gene cluster originating
from Pseudomonas stutzeri A1501. The genes were codon-
optimized and expression was uncoupled from its normal
osmotic stress-induced transcriptional control by employ-
ing a promoter that is constitutively active in C. glutami-
cum. We demonstrate here that the newly constructed
recombinant C. glutamicum strain excretes most of the
formed ectoine/hydroxyectoine into the growth medium.
We further optimized its performance by elimination of
by-product formation through metabolic engineering and
benchmarked the ectoine production performance in fed-
batch fermentation.
Results
Design of the cellular chassis for ectoine synthesis
For heterologous synthesis of ectoine in C. glutamicum,
a basic lysine-producer was chosen as a suitable genetic
background. This strain, C. glutamicum LYS-1, possesses
a feedback-resistant aspartokinase (LysC-T311I) [53] and
thereby circumvents the native biochemical pathway
regulation for the synthesis of ASA that normally keeps
the cellular pool of this central metabolite under tight
Figure 1 (See legend on next page.)
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Figure 1 Metabolic engineering strategy for heterologous production of ectoine and 5-hydroxyectoine in Corynebacterium glutamicum
from the building block L-aspartate-β-semialdehyde. L-aspartate-β-semialdehyde is synthesized through the concerted actions of the
aspartokinase (Ask; EC: 2.7.2.4) and aspartate-semialdehyde-dehydrogenase (Asd; EC: 1.2.1.11). It is then converted into the compatible solutes
ectoine and 5-hydroxyectoine, respectively, by the L-2,4-diaminobutyrate transaminase (EctB; EC: 2.6.1.76) to form L-2,4-diaminobutyrate, a
metabolite that is then acetylated by the 2,4-diaminobutyrate acetyltransferase (EctA; EC: 2.3.1.178) to produce N-γ-acetyl-2,4-diaminobutyrate,
which is subsequently cyclized via a water elimination reaction by the ectoine synthase (EctC; EC: 4.2.1.108), to yield ectoine. Ectoine can then
serve as the substrate for the formation of 5-hydroxyectoine through the activity of ectoine hydroxylase (EctD; EC: 1.14.11). Heterologous production
in C. glutamicum was mediated via the codon-optimized ectABCD gene cluster based on that present in P. stutzeri A1501. The synthetic gene cluster was
designed to be constitutively expressed from the promoter for the tuf gene from C. glutamicum. For genome-based integration via double-recombination
event, the construct was equipped with flanking regions of about 560 bp DNA sequences derived from the upstream and downstream regions of the
ddh gene. Recognition sites for the restriction enzyme SpeI were added to facilitate cloning of this DNA fragment into the vector pClik_int_sacB (A). The
ddh gene, encoding diaminopimelate dehydrogenase, was chosen as integration site to minimize competing carbon flux towards lysine. Tracer studies
with 3-13C glucose identified this biosynthetic branch as major contributor to the overall lysine flux under conditions with high ammonium availability
which is readily present under industrial-scale production conditions (B).
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molecule for ectoine biosynthesis (Figure 1A) was aimed
with the chosen C. glutamicum starter strain LYS-1.
This strain is known to overproduce lysine which might
arise as potential by-product in the aspired ectoine pro-
ducer. In C. glutamicum, lysine can be formed via two
alternative metabolic routes – the succinylase pathway
and the dehydrogenase pathway [55]. From these, the
dehydrogenase pathway was identified by 13C tracer
studies as major contributor to the overall lysine flux at
high ammonium levels (Figure 1B, Additional file 1)
which are readily present in production processes at in-
dustrial scale. The ddh gene, encoding diaminopimelate
dehydrogenase, was hence chosen as integration site for
genome-based implementation of the ectoine gene clus-
ter. The intention was to lower the carbon flux via this
pathway towards lysine to a priori diminish lysine
formation as a major competitor for the building block
ASA (Figure 1).
Design of the genetic construct for host engineering
For our recombinant DNA experiments, we chose an
ectABCD gene cluster from an isolate of Pseudomonas
stutzeri [56], a well-known ectoine and hydroxyectoine
producer [33,37]. To adjust the codon usage of the ect
gene cluster employed by the natural host strain P. stut-
zeri A1501 to that preferred by C. glutamicum, we chem-
ically synthesized and codon-optimized the ectABCD
genes (Additional file 2). We uncoupled the expression of
the naturally osmotically inducible operon [33] from
osmotic-stress-derived signal transduction processes by
positioning the synthetic ectABCD gene cluster under
control of a strong and constitutive C. glutamicum
promoter that is driving the expression of the structural
gene (tuf ) for the elongation factor Tu of C. glutamicum
[57]. The resulting tufp-ectABCD construct was addition-
ally provided at its 5’- and 3’-ends with regions flanking
the non-essential diaminopimelate dehydrogenase gene(ddh) for its targeted integration into the chromosome of
C. glutamicum by a double-homologous recombination
event (Figure 1A). Successful integration and inactivation
was verified by PCR analysis and determination of the
DDH activity, which was found absent in the novel strain.
In this way, a recombinant C. glutamicum strain ECT-1
was constructed that carried a single-copy of the tufp-
ectABCD gene cluster stably integrated into a well-
defined site in the chromosome and that should be
able to produce ectoine/hydroxyectoine in the absence
of osmotic stress.
The recombinant C. glutamicum strain efficiently
produces ectoine from glucose
To evaluate the pattern and levels of ectoine/hydroxyec-
toine production in the newly constructed ECT-1 strain,
we grew it in a chemically defined minimal medium with
glucose as the carbon source. This experiment revealed
that the tufp-ectABCD gene cluster was functionally
expressed, and we observed that the ECT-1 strain pro-
duced and secreted ectoine in shake-flask cultures
already from the early growth phase (Figure 2). Ectoine
accumulated in the culture supernatant up to a final titer
of 1.3 mM after the cells had completely depleted their
carbon source. About 2% of the consumed glucose was
converted into ectoine as reflected by the molar yield of
19.4 mmol mol-1 (Table 1). Hydroxyectoine was also de-
tected in the culture supernatant, albeit at a rather low
level (< 0.1 mM). In addition to both ectoines, strain
ECT-1 also secreted substantial amounts of L-lysine into
the medium, 2.3 mM in total. L-lysine production thus
exceeded that of the desired products ectoine and
hydroxyectoine. We also quantified the intracellular con-
centrations of ectoine and hydroxyectoine in strain
ECT-1. This revealed that ectoine accumulated up to
130 μmol (gcdm)
-1 in the cytosol. Hydroxyectoine was de-
tected in significantly lower amounts (~ 5 μmol (gcdm)
-1).
Hence, the relative amounts of these two compounds
Figure 2 Cultivation profile of the heterologous ectoine producer strain C. glutamicum ECT-1. The C. glutamicum strain ECT-1 was
cultivated in shake flasks at 30°C in a chemically defined medium. At the indicated time intervals, consumption of glucose and the extracellular
accumulation of L-lysine, ectoine, and 5-hydroxyectoine were monitored. The data shown represent mean values and corresponding standard
deviations from three biological replicates.
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production titers measured for ectoine and hydroxyectoine
in the supernatant (Figure 2).
Increased temperature positively affects ectoine and
hydroxyectoine production
The optimal cultivation temperature for the recombin-
ant production of ectoine and hydroxyectoine by strain
ECT-1 was assessed by miniaturized cultivations in aTable 1 Growth and production performance of the C. glutam
cultivation on a mineral salt medium with glucose as carbon
C. glutamicum LYS-1 C. glutamicu
Temperature 30°C 30°C
Rates
μ [h-1] 0.38 ± 0.01 0.34 ± 0.00
qs [mmol g
-1 h-1] 4.86 ± 0.10 3.82 ± 0.08
qEct [mmol g
-1 h-1] -- 0.07 ± 0.01
qLys [mmol g
-1 h-1] 0.39 ± 0.02 0.20 ± 0.01
Yields
YX/S [g mol
-1] 82.1 ± 1.3 87.2 ± 2.8
YEct/S [mmol mol
-1] -- 19.4 ± 1.5
YLys/S [mmol mol
-1] 81.2 ± 3.2 53.8 ± 2.5
YTre/S [mmol mol
-1] 9.4 ± 0.4 5.6 ± 0.1
YAKG/S [mmol mol
-1] 0.0 ± 0.0 2.6 ± 0.4
YEctOH/S [mmol mol
-1] -- 0.6 ± 0.0
The data represent mean values and standard deviations from three biological repl
product formation (qP). Additionally, the yield for biomass (YX/S), ectoine (YEct/S), lysi
(YEctOH/S) are given.temperature range between 27°C and 42°C. Interestingly,
this revealed that ectoine production was improved by
higher temperature (Figure 3). As compared to the refer-
ence cultivation conditions for strain ECT-1 at 30°C,
secretion was more than doubled when the temperature
was increased to 35°C. The enhanced production per-
formance was also reflected by a slight increase of
the intracellular ectoine level. The higher cultivation
temperature also positively influenced the intracellularicum strains LYS-1 [53], ECT-1 and ECT-2 during batch
source at 30°C (LYS-1, ECT-1, ECT-2) and 35°C (ECT-2)
m ECT-1 C. glutamicum ECT-2 C. glutamicum ECT-2
30°C 35°C
0.36 ± 0.00 0.34 ± 0.02
3.51 ± 0.05 3.74 ± 0.10
0.09 ± 0.01 0.12 ± 0.01
0.00 ± 0.00 0.00 ± 0.00
101.5 ± 0.6 90.9 ± 6.3
24.6 ± 0.6 32.0 ± 0.8
0.0 ± 0.0 0.0 ± 0.0
7.2 ± 0.9 6.7 ± 0.2
1.0 ± 0.1 1.9 ± 0.1
0.6 ± 0.0 0.9 ± 0.1
icates and denote the specific rates for growth (μ), substrate uptake (qS), and
ne (YLys/S), trehalose (YTre/S), α-ketoglutarate (YAKG/S), and hydroxyectoine
Figure 3 Influence of cultivation temperature on the growth
and ectoine production performance of C. glutamicum ECT-1.
Strain ECT-1 was grown in chemically defined medium with glucose
on a miniaturized scale at the indicated growth temperatures. The
specific growth rate μ, ectoine secretion (Ectex), and intracellular
accumulation of ectoine (Ectint) and hydroxyectoine (EctOHint) were
determined. Ectoines were quantified after 10h (27°C, 30°C, 35°C)
and 20h (42°C) of cultivation. The data shown represent mean
values and corresponding standard deviations from three
biological replicates.
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of strain ECT-1 as reflected by a 28% increase of the
specific growth rate (Figure 3). The higher ectoine con-
centration in the supernatant was taken as positive
indication for a better production performance at 35°C.Elimination of lysine secretion generates a second-
generation ectoine producer
Ectoine production of the first-generation producer
ECT-1 was limited by substantial carbon loss related to
L-lysine synthesis and subsequent secretion of this
amino acid into the growth medium. To avoid excretion
of L-lysine, the gene (lysE) for the L-lysine exporter LysE
[58] was inactivated in the genetic background of strain
ECT-1 to yield the second-generation ectoine producer
C. glutamicum ECT-2. Validation was carried out by
PCR as previously described [58]. First, the novel ECT-2
strain was cultivated in shake flasks in glucose minimal
medium at 30°C to allow a direct comparison of the
performance with the parent ECT-1 strain. We found
that the deletion of the lysE gene had a beneficial influ-
ence on ectoine production. As compared to the parent
strain ECT-1, the molar ectoine yield was increased by
27% (Table 1). At the same time, L-lysine secretion was
completely eliminated (Table 1). However, the additional
carbon available for strain ECT-2 was not completely
channeled towards ectoine production; it was instead
recruited for biomass formation (Table 1). To take bene-
fit from the improved ectoine production at elevated
growth temperature observed for strain ECT-1 (Figure 3),
we also investigated in greater detail the performance of
strain ECT-2 at 35°C. Similarly to the ECT-1 strain, the
higher growth temperature positively influenced the pro-
duction performance of the strain ECT-2. The yield was
increased from 25 mmol mol-1 at 30°C to 32 mmol mol-1
at 35°C. When compared to the basic proof-of-concept
approach, the allover ectoine yield was improved in strain
ECT-2 by 65%. In addition, strain ECT-2 did not suffer
from high fluxes to the by-product L-lysine. We noted
that the growth performance of strain ECT-2 was hardly
affected by the elevated cultivation temperature (Table 1);
however, the yield in biomass was reduced, likely as a
stress response of C. glutamicum to the increase in
growth temperature. Taken together, the substantial-
ly improved ectoine yield and the unaffected glucose
uptake rate of strain ECT-2 resulted in an about
70% increased specific productivity of the second-gen-
eration ectoine producer C. glutamicum ECT-2
(Table 1).
Ectoine synthesis affects the intracellular pools of amino
acids of the aspartate family
ASA is an important metabolite and critical branch
point with regard to biosynthesis of the aspartate family
of amino acids [21]. Since ectoine biosynthesis is
dependent on a good supply of ASA as well (Figure 1A)
[32,33], we examined the intracellular pools of amino
acids belonging to the aspartate family. Most desirable,
integration of the synthetic ectoine cluster into the
DDH lysine branch resulted in substantial decrease of
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petitor in the ECT-1 strain (Table 2). This was taken
as positive indication of a successfully lowered carbon flux
towards lysine biosynthesis, thus increasing the ASA
availability for the novel product ectoine. Ectoine indeed
accumulated in substantially higher levels in the cytosol
than lysine did (Table 2). Upon elimination of the lysine
exporter, however, the metabolite pattern completely
changed. The novel ECT-2 strain accumulated up to
77μmol (gcdm)
-1 of lysine even exceeding that of the basic
lysine producer LYS-1 by more than three fold. Simultan-
eously, the ectoine level dropped substantially (Table 2).
Obviously, elimination of lysine secretion did not cir-
cumvent high carbon fluxes towards this amino acid
but resulted in increased intracellular accumulation.
In addition to the most obvious changes regarding
the intracellular lysine and ectoine level, also the
formation of aspartate and threonine was slightly affected.
As compared to the parent lysine producer LYS-1, their
cytosolic levels were slightly reduced in the synthetic
ectoine cell factories. The intracellular asparagine level,
however, was strongly increased. Whereas only marginal
amounts were found in LYS-1, both ECT-1 and ECT-2
exhibited comparably high intracellular asparagine levels,
also competing with ectoine biosynthesis and secretion.
The cultivation temperature only had a marginal effect on
the intracellular amino acid accumulation. For ectoine, a
slight trend towards higher accumulation was observed
at 35°C as indicated by the miniaturized temperature
screening.
Performance of the ectoine-producing C. glutamicum
strain ECT-2 under fed-batch conditions
To assess the overall production performance of the
ECT-2 strain under conditions more relevant for an in-
dustrial process, we benchmarked ectoine production by
this strain in a fed-batch process. Ectoine was secreted
from early on during cell growth and accumulated in theTable 2 Concentration of free intracellular amino acids of the
the lysine-producing C. glutamicum strains LYS-1 and its ecto
C. glutamicum ECT-2
Strain Aspartate [μmol gcdm
-1] Asparagine [μmol gcdm
-1]
(A)
C. glutamicum LYS-1 11.8 ± 3.3 0.7 ± 0.3
C. glutamicum ECT-1 8.1 ± 2.9 24.6 ± 6.0
C. glutamicum ECT-2 7.0 ± 0.3 20.1 ± 4.9
(B)
C. glutamicum LYS-1 9.1 ± 0.9 1.4 ± 0.2
C. glutamicum ECT-1 7.6 ± 0.6 28.1 ± 4.0
C. glutamicum ECT-2 7.9 ± 0.6 17.0 ± 2.4
Cells were grown at 30°C (A) and 35°C (B), respectively in mineral salt medium. The
replicates, each sampled at three different optical densities (OD 2, OD 4 and OD 8).growth medium to a final concentration of 4.5 g L-1 after
16 h of fermentation (Figure 4A). We observed that the
production efficiency differed significantly between the
batch and the feeding phase of the process (Figure 4B).
The initial 45 g L-1 glucose was already consumed after
8 h and mainly served for the production of biomass
(Figure 4A). This was reflected by the rapid increase of
the optical density to OD660 100. As soon as the feeding
was started, a shift in the production pattern towards
the formation of ectoine was observed. Overall, the feed-
ing phase contributed to more than 80% of the total
ectoine production (Figure 4). The yield obtained during
the batch phase (28 mmol mol-1) was very similar to the
yield obtained during shake flask cultivation of strain
ECT-2 (Table 1). In the feeding phase, however, it
increased 10-fold up to ~300 mmol mol-1 (Figure 4B).
This substantial increase provided an overall space time
yield of 6.7 g L-1 ectoine per day.
Discussion
The stabilizing and function-preserving effects of ectoines
have spurred considerable interests in these compounds
and have led to the development of a variety of practical
applications [7,13,14]. As a consequence, ectoine and its
derivative hydroxyectoine are considered as valuable nat-
ural microbial products and they have gained significant
market value in recent years. Their biotechnological pro-
duction has reached the scale of tons on an annual basis.
The industrial production of ectoines is currently achieved
by bacterial milking of H. elongata [8,20], a process that
has recently been improved by the inclusion of mutants of
this bacterium that cannot catabolize ectoines and those
that accumulate these compounds in the high salinity
medium as a result of a defect in the ectoine/hydroxyec-
toine-specific TeaABC uptake system [36]. We report here
the construction and characterization of a synthetic micro-
bial cell factory for the production of ectoine that relies on
the robust metabolism of C. glutamicum [59,60]. Thisaspartate-family and of intracellular ectoine of
ine-producing derivatives C. glutamicum ECT-1 and
Threonine [μmol gcdm
-1] Lysine [μmol gcdm
-1] Ectoine [μmol gcdm
-1]
5.1 ± 0.9 23.4 ± 3.1 --
3.9 ± 0.6 14.5 ± 4.1 126.8 ± 25.5
3.0 ± 0.9 76.7 ± 11.3 34.1 ± 14.2
6.8 ± 0.5 24.4 ± 6.3 --
6.5 ± 0.4 16.3 ± 2.0 158.5 ± 20.7
5.2 ± 0.4 52.8 ± 12.6 36.1 ± 7.6
data represent mean values with standard deviations from two biological
Figure 4 Production performance of the advanced ectoine-producer strain C. glutamicum ECT-2 during fed-batch fermentation.
Cultivation profile of strain ECT-2 (A), and ectoine yield achieved in the different cultivation phases (B) are shown. The oxygen saturation in
the fermenter was kept constant at 30% by variation of the stirrer velocity and the aeration rate. Automated feeding was initiated by a
pO2-based signal [53]. Glucose concentration was thereby kept below 5 g L
-1. The data shown represent mean values from two independent
fermentation experiments.
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production processes which are responsible for its tremen-
dous rise and success as industrial production host [46].
Novel C. glutamicum designer-bug enables decoupling of
ectoine production from high salinity in a marker-free
host system
We build on the considerable knowledge base for the gen-
etic manipulation and large-scale fermentation processes
of the industrial workhorse C. glutamicum [46]. Most
advantageous, the C. glutamicum genome sequence lacks
ectoine catabolic genes [61] eliminating product loss due
to the reuse of ectoine and hydroxyectoine as carbon or
nitrogen sources - a drawback of natural producer
H. elongata [36]. In developing the synthetic C. glutamicum
ectoine cell factory several strategies were combined
simultaneously to optimize its production. Adaptation of
the codon usage appeared promising as this strategy has re-
cently proven beneficial for the heterologous production of
diaminopentane recruiting lysine decarboxylase from E. coli
[62]. Expression control via the constitutively active tuf pro-
moter of C. glutamicum [57,62] not only decoupled
ectABCD expression from its natural osmo-stress respon-
sive regulation [33] but also provided a simple and robust
promoter system with no specialized needs for the control
of its activity. Beyond this, the careful design of the cellular
chassis guaranteed good supply of the building block ASA
which is normally tightly controlled in many microorgan-
isms including C. glutamicum [21,54]. In addition, and in
an effort to diminish carbon flux towards L-lysine, the de-
hydrogenase branch of L-lysine biosynthesis [63,64] was
inactivated (Figure 1A, B). In comparison to plasmid-based
systems [33,37,43,44] our strategy benefits from a
stable genome-based integration of the synthetictufp-ectABCD gene cluster (Figure 1B), an approach that
has also been employed for the recombinant production
of ectoines by H. polymorpha [45]. However, high-copy
plasmids could provide increased expression levels of the
biosynthetic genes which appears to be limiting the pro-
duction efficiency at least of the ECT-2 strain. Towards
industrial scale production, multiple genome-integrated
gene copies and optimization of ribosomal binding sites
appear particularly attractive. Constitutive gene expression
in the synthetic C. glutamicum cell factory obviated the
need for the use of high-salinity growth media, conditions
that are typically required to trigger enhanced expression
of these genes in natural producers [24,26,27] such as
H. elongata [8]. Our synthetic cell factory thus avoids the
considerable drawbacks of high-salinity growth media
during fermentation processes that invoke corrosion prob-
lems on the reactor systems [44] and thereby drive up
the costs for their appropriate design and maintenance.
Related to the economic relevance, also previous studies
have addressed the issue of a salt-decoupled ectoine
production with the natural producers P. stutzeri and
Chromohalobacter salexigens, and the heterologous hosts
H. polymorpha and E. coli [37,43-45].
Combined process and strain engineering increases ectoine
production in C. glutamicum
As successful proof of concept, the first generation
C. glutamicum ECT-1 strain revealed salinity-decoupled
ectoine and hydroxyectoine production and secretion.
Interestingly, the summed molar yields of L-lysine and
ectoine added up to 73.2 mmol mol-1, a value that perfectly
matches with the L-lysine yield of the parent strain LYS-1
[53]. Hence, the carbon demand for ectoine synthesis
seems to be completely satisfied by the cells on the
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inated in the basic ectoine producer. This issue was
addressed in a second round of metabolic engineering
through inactivation of the gene coding for the L-lysine
exporter LysE. This strategy has recently been applied for
optimized diaminopentane production by C. glutamicum
[65]. Beyond the 27% gain in ectoine yield (Table 1),
the inactivation of the lysine exporter avoided a con-
tamination of the excreted ectoine, a feature that will
clearly facilitate the downstream processing for the
recovery of ectoine from the culture broth. Further
improved ectoine production was then achieved by an
increase in the growth temperature from 30°C to 35°C.
In combination, genetic and process engineering proved
to be highly beneficial as reflected in a 65% increased yield
and a 70% increased specific productivity (Table 1). A
rather unexpected finding of our study was the observa-
tion that the recombinant strain produced so little hydro-
xyectoine (Table 1). This is surprising because P. stutzeri
A1501 on whose genetic blueprint we build our synthetic
ectABCD gene cluster produces hydroxyectoine very effi-
ciently and in much greater quantities than ectoine [33,37].
We can currently not comment about why there is
so little hydroxyectoine formed by the C. glutamicum
[tufp-ectABCD] strains. Overall, both recombinant
C. glutamicum ectoine producers already performed
admirably in shake-flask experiments. They exhibited
excellent specific production rates of 9.9 mg g-1 h-1 (ECT-1)
and 17.1 mg g-1 h-1 (ECT-2), thus exceeding that of
the native and the heterologous ectoine production
hosts H. elongata (7.1 mg g-1 h-1) [20] and E. coli
(2 mg g-1 h-1) [43]. However, a closer examination of the
finally achieved yield of 32 mmol mol-1 revealed, that it
was so far not possible to harness the complete carbon
used by C. glutamicum LYS-1 for L-lysine synthesis for
the recombinant production of ectoine.
High-cell density fermentation reveals excellent
production performance
To take benefit from high cell densities [53,66] that
cannot readily be achieved in shake-flask experiments
we benchmarked the performance of the second gener-
ation ectoine producer C. glutamicum ECT-2 under
carefully controlled fed-batch conditions. We found that
the ectoine production efficiency differed significantly
during the batch and the feeding phase of the fermenta-
tion process. That kind of desired shift in the product
spectrum is often intentionally induced at industrial
scale production by appropriate process operations. In
general, this leads to an optimized channeling of the
substrate to the desired product within the feeding-
phase [53,67-69]. Similarly, we observed an admirable
10-fold increase of the ectoine yield in the feeding phase
of the ECT-2 strain fermentation (Figure 4B). Thoughthere was detectable growth-associated ectoine produc-
tion during the batch phase, the predominant fraction of
ectoine seemed to be produced by cells during the feed-
ing phase. The finally achieved titer of 4.5 g L-1 already
approached to that of currently described industrial
production systems [38,39,41]. The C. glutamicum cell
factory, however, takes high benefit from the fast growth
and vitality. The excellent performance of the C. gluta-
micum strain ECT-2 under fed-batch conditions allowed
the synthetic cell factory to achieve an overall space-
time yield of 6.7 g L-1 ectoine per day which is among
the highest productivities reported so far in the literature
[38,39,41]. Better performance was, so far, only achieved
with H. boliviensis [38], and Chromohalobacter salexi-
gens [41]. These do, however, rely on high salinity and
involve complex process operation strategies [41] thus
driving up the production costs.
Metabolic changes point at potential bottlenecks in ectoine
production
When introducing the synthetic ectoine gene cluster in
lysine producing C. glutamicum LYS-1, carbon flux
within the cell was partly rerouted from the common
intermediate ASA to ectoine as indicated by the drop in
extracellular and intracellular lysine ([53], Table 2), an
effect equally observed at 30°C and 35°C. However,
elimination of lysine secretion resulted in a strong
increase of the intracellular pool of this amino acid. The
additional carbon, now potentially elevating the ASA
pool, was not efficiently recruited for driving ectoine
biosynthesis. Obviously, the native lysine route is still su-
perior to the non-native route towards the novel product
ectoine despite the elimination of the dehydrogenase
branch. In subsequent rounds of strain engineering, this
might be targeted by additional down-regulation of other
lysine biosynthetic genes including dihydrodipicolinate
synthase (dapB) and diaminopimelate decarboxylase
(lysA) previously identified as key reactions for lysine
production [53]. In addition, manipulating the strength
of the ribosome-binding sites of the various ect genes
might improve their expression. An additional issue
involves the transport processes related to the ectoine
metabolism. Most favorable for our production process
C. glutamicum excretes ectoine into the growth medium,
a feature that was also observed for other recombinant
ectoine production systems [43,45]. So far the intracellular
metabolite levels (Table 2) do not suggest limitations in
the transport processes but experience has shown that
engineering the excretion systems for amino acids and
related compounds is beneficial for the performance
of C. glutamicum [58,65,70-73]. In addition, it appears
even important to address the uptake system of C. gluta-
micum comprising the three transporter EctP, LcoP, and
ProP [74]. In native producers, these transport systems
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tants from natural resources [75], but they also function
as salvaging systems to retrieve compatible solutes that
leak or are actively released from the producer cells
[36,76,77]. As previously shown for the production of
aromatic amino acids [78,79], the production efficiency of
C. glutamicum might significantly suffer from product re-
uptake into the cell. In addition, there is strong indication
that the compatible solute transporter TeaABC in H. elon-
gata is integrated in the regulation of ectoine biosynthesis.
De novo biosynthesis of the cell is immediately decreased
when externally supplied ectoine is taken up via TeaABC
[36]. As the regulatory mechanism is so far unknown,
similar regulation patterns involving the C. glutamicum
ectoine transporters might also limit the biosynthetic
efficiency in the recombinant production host.
Conclusion
In contrast to the currently used H. elongata strain for
the commercial production of ectoines [7,8], or other
microbial species that have been suggested as alternative
natural producers [33,37-40], C. glutamicum has a long
history for the industrial level production of valuable
natural products by large-scale fermentation procedures
[73,80]. Knowledge gained during the development of
C. glutamicum into an excellent performing microbial
cell factory [53,68,81] can now be brought to bear in a
scale-up process for ectoine production by the recombinant
C. glutamicum [tufp-ectABCD] ECT-2 strain. In addition,
the ability to readily manipulate the genetic blueprint
of C. glutamicum on a genome-wide scale [50,53,82]
will allow the application of rational and systems-wide
metabolic engineering approaches to further improve theTable 3 Description of the C glutamicum strains and plasmids
ectoine and hydroxyectoine
Strain Description
C. glutamicum LYS-1 C. glutamicum ATCC 13032 + amino acid
encoding aspartokinase
C. glutamicum ECT-1 LYS-1 + genome-based integration of the
cluster of P. stutzeri into the ddh gene (N
dehydrogenase [ddh: tufp-ectABCD]
C. glutamicum ECT-2 ECT-1 + deletion of lysE gene (NCgl1214)
Plasmids Description
pTC Expression vector for DNA-methyltransfe
tetracycline resistance as selection marke
C. glutamicum-specific DNA-methylation
pClik int sacB Integrative transformation vector for C. g
and sacB as selection markers.
pClik int sacB ectABCD Integrative transformation vector for the
ectoine/hydroxyectoine gene cluster der
of C. glutamicum
pClik int sacB ΔlysE Integrative transformation vector for deleperformance of the second generation ectoine producer
ECT-2. The success of these approaches has recently
unequivocally been demonstrated in the development
of highly efficient L- lysine [53] and diaminopentane
[62,68,83] C. glutamicum cell factories.
Materials and methods
Microorganisms and plasmids
In the present work, the ATCC 13032-derived L-lysine-
overproducing C. glutamicum strain LYS-1 [53] was
used as host for ectoine and hydroxyectoine production.
The strains and plasmids employed in this study are
listed in Table 3. Amplification of transformation vectors
during genetic engineering work was carried out in
Escherichia coli strains DH5α and NM522 (Invitrogen,
Carlsbad, CA, USA) [53].
Strain construction
The heterologous production of ectoine in C. glutami-
cum was based on the ectABCD biosynthetic gene clus-
ter from Pseudomonas stutzeri A1501 [33]. We attached
to the 5’ end of the ectABCD gene cluster a 200-bp
DNA segment that carries the strong and constitutively
active promoter driving the expression of the structural
tuf gene (NCgl0480) of the elongation factor Tu of
C. glutamicum [57]. Additionally, the construct was
flanked by ~ 560 bp-sized homologous recombination sites
for genome-based integration of the construct into the
structural ddh gene (NCgl2528), encoding diaminopi-
melate dehydrogenase. Artificial SpeI digestion sites
were added at the 5’ and 3’ end. The 4577 bp-sized
construct (Figure 1A) was synthesized by Geneart
(Life Technologies, Regensburg, Germany), whereby theused in the present work for heterologous production of
Reference




, encoding the lysine exporter This work
Reference
rase of C. glutamicum, ORI for E. coli and
r. Used in E. coli NM522 to add the
pattern to the integrative transformation vector.
[53]
lutamicum with MCS, ORI for E. coli, and KanR [57]
integration of the codon-optimized biosynthetic
ived from P. stutzeri A1501 into the ddh locus
This work
tion of the lysine exporter lysE [65]
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using the proprietary GeneOptimizer® software (Geneart, Life
Technologies, Regensburg, Germany). The DNA sequence
of the codon-optimized ectABCD variant gene cluster along
with the original sequence of P. stutzeri A1501 is given in
the supplement. Insertion of the synthetic construct contain-
ing the ectABCD gene cluster into the integrative transform-
ation vector pClik_int_sacB [57] was carried out at the
unique SpeI site. Vector amplification in the E. coli strains
DH5α and NM522, purification of plasmid DNA, and its
transformation into E. coli and C. glutamicum strains were
performed as described previously [84]. The codon-
optimized ectABCD gene cluster was inserted by DNA trans-
formation into the ATCC 13032-derived C. glutamicum
strain LYS-1 carrying a feedback deregulated aspartokinase
[85]; this yielded the recombinant C. glutamicum strain
ECT-1. The correct integration into the chromosome of
strain ECT-1 at the non-essential diaminopimelate
dehydrogenase gene (ddh) was verified by PCR using
the ddh-specific primers ECT_fw (5’-AGAGTACCTGG
GACGCAGCGTCG-3’) and ECT_rev (5’- CGTCGCGTG
CGATCAGATCGGT-3‘) and a KAPAHiFi PCR-Kit (Peq-
lab, Erlangen, Germany). The PCRs were performed under
conditions recommended by the manufacturers of the
PCR-Kit. The PCR yielded the expected ~ 3.5-kb product
comprising the synthetic P. stutzeri ectABCD genes fused
to the C. glutamicum tuf promoter (Figure 1). Concomitant
inactivation of the chromosomal ddh gene was verified in
the C. glutamicum ECT-1 strain by assaying diaminopime-
late dehydrogenase (DDH) enzyme activity. The parent
C. glutamicum LYS-1 strain exhibited a DDH enzyme
activity of 300 mU mg-1, whereas no DDH enzyme activity
(< 0.1 mU mg-1) was detected in the recombinant
ddh::tufp-ectABCD C. glutamicum strain ECT-1. A
deletion of the gene (lysE) encoding the L-lysine exporter
of C. glutamicum was introduced into the genome of
strain ECT-1 as described previously [65]; the resulting
strain was named C. glutamicum ECT-2.
Cultivation of C. glutamicum strains in shake flasks
The preparation of the inoculum involved two subse-
quent pre-cultivation steps using either complex or
glucose-based minimal medium [62,86]. The main culti-
vation was then carried out in a chemically defined min-
eral salt medium with glucose as the carbon source [84].
If not specified otherwise, C. glutamicum was grown in
baffled shake flasks with a 10% filling volume at 30°C
and 230 rpm on an orbital shaker (Multitron, Infors AG,
Bottmingen, Switzerland; 5 cm diameter). For 13C label-
ing experiments, the naturally labeled glucose was re-
placed by an equimolar amount of 99% [3-13C]-glucose
(Cambridge Isotope Laboratories, Inc., Andover, MA,
USA). The tracer studies were carried out at an am-
monium sulfate concentration of 5 g L-1 and 50 g L-1,respectively, to study the split ratio of the branched
lysine biosynthesis.
Miniaturized cultivation of C. glutamicum strains
Small-scale cultivations of C. glutamicum strains were
carried out in 1 mL mineral salt medium in 48-well flower
plates (m2p-labs, Baesweiler, Germany) at 700 rpm using
the Biolector system (DASGIP, Jülich, Germany). The
temperature was varied between 27°C and 42°C. To avoid
evaporation of the medium, the plates were sealed
with a gas-permeable membrane (Aera Seal, Sigma Aldrich,
Steinheim, Germany). Inoculum preparation involved shake
flask cultivation as described above, and these cells were
then subsequently used to inoculate the multi-well plates to
an initial optical density of 0.3. Cell growth was monitored
online via measurement of the optical density at 620 nm.
After 10 h (27°C, 30°C, 35°C) and 20 h (42°C), extra-
cellular and intracellular accumulation of ectoines was
determined. Process monitoring, data collection, and
data processing were carried out with the software suit
BioLection (m2p-labs, Baesweiler, Germany).
Fed-batch cultivation for ectoine production in
C. glutamicum
Production performance of C. glutamicum ECT-2 was
investigated by fed-batch cultivation in (1000 mL) biore-
actors with 300 mL starting volume (SR0700ODLS,
CWD4 Bioblock, DASGIP AG, Jülich, Germany). The
reactors were equipped with a pH electrode (Mettler
Toledo, Giessen, Germany) and a pO2 electrode (Hamilton,
Höchst, Germany). Data acquisition and online control of
the process were carried out with the DASGIP control soft-
ware. The pH was kept constant at 6.9 by automated
addition of 25% NH4OH (MP8 pump system, DASGIP AG,
Jülich, Germany). Dissolved oxygen was maintained at sat-
uration above 30% by variation of the stirrer speed and the
aeration rate; these values were initially set to 0.5 vvm and
400 rpm, respectively. The temperature was kept constant
at 35°C (CWD4 Bioblock, DASGIP AG, Jülich, Germany).
The feeding was automatically controlled via the dissolved
oxygen level [53]. Inoculum preparation involved pre-
cultivation for 10 hours in the fermentation batch medium
(MMYE-1 medium [87]), and cells were harvested by
centrifugation (5350 × g, 10 min, Heraeus Multifuge 4KR,
Thermo Fisher Scientific, Schwerte, Germany). The cultiva-
tion of the cells was carried out in MMYE-1 medium [87]
without adding homoserine. For preparation of the feeding
solution, the glucose and ammonium sulfate concentrations
were increased to 350 g L1 and 50 g L-1, respectively.
Sample preparation for metabolite quantification
For the quantification of glucose and of secreted prod-
ucts, the biomass was separated from the culture broth
by centrifugation (13000 × g, 5 min, 4°C and 10000 × g,
Becker et al. Microbial Cell Factories 2013, 12:110 Page 12 of 15
http://www.microbialcellfactories.com/content/12/1/11015 min, 4°C, centrifuge 5415R Eppendorf, Hamburg,
Germany). For the quantification of intracellular concen-
trations of ectoine and hydroxyectoine, cells from 1 mL
culture were harvested by centrifugation (13000 × g, 5
min, 4°C). The exact sample volume was determined
gravimetrically on an analytical balance (CP255D,
Sartorius, Göttingen, Germany). In parallel, the optical
density was measured to quantify the harvested biomass
amount. The supernatant was decanted, and the cells were
subsequently dried for 12 h in a speedvac apparatus
(Concentrator 5301, Eppendorf, Hamburg, Germany).
Cells were re-suspended in 500 μL Bligh & Dyer solution
(MeOH:CHCl3:H20, 10:5:2) and disrupted mechanically
(FastPrep®-24, 3 min, 4 m s-1, MP Biomedicals, Santa Ana,
USA) using glass beads with a diameter of 0.04 mm. The
disruption step was repeated, after adding 130 μL H2O
and 130 μL chloroform to the slurry. Phases were then
separated by centrifugation (10000 × g, 15 min centrifuge
5415R, Eppendorf, Hamburg, Germany). The aqueous
phase was transferred into a clean reaction tube and sub-
sequently evaporated to dryness in a speedvac apparatus.
The remaining solids were dissolved in 80–100 μL H2O
and centrifuged (15 min, 10000 × g, 4°C); metabolites were
then assessed by HPLC analysis. Sampling for quanti-
fication of the intracellular amino acid concentration was
performed by fast filtration [88].
Substrate and product analysis
Glucose was quantified enzymatically in 1:10 diluted
supernatant samples using the biochemical analyzer YSI
2700 Select (Kreienbaum, Langenfeld, Germany) [84].
Amino acids were quantified by HPLC (Agilent 1200 Series,
SIM, Oberhausen, Germany) involving pre-column deriva-
tization and fluorescence detection as described previously
[89]. Quantification of ectoine and hydroxyectoine was per-
formed by HPLC analysis (LaChrome, Merck-Hitachi,
Darmstadt, Germany) using a ProntoSil C18 AQ+ column
(125 × 4 mm, Knauer, Berlin, Germany) with a Nucleosil
C18 AQ+ pre-column (120 × 5 mm, Knauer, Berlin,
Germany). As mobile phase, a phosphate buffer was used
(0.8 mM K2HPO4; 6.0 mM Na2HPO4, pH 7.6) at a flow rate
of 1 mL min-1 and at 40°C. The injection volume was 2 μL.
Detection was carried out with a diode array detector
(L7450, LaChrome, Merck-Hitachi, Darmstadt, Germany)
at 220 nm. Quantification of cell concentration was
carried out by measuring the optical density (OD660). The
cell dry mass was determined as described previously [89].
GC-MS labeling analysis
Quantification of the 13C labeling of proteinogenic amino
acids and of diaminopimelate from hydrolyzed biomass
was carried out by GC-MS (GC 7890A, inert MSD 5979C,
Agilent Technologies, Waldbronn, Germany) as described
previously [90]. Derivatization and GC-MS measurementwas then carried out as described for protein-bound
amino acids [90]. Selected ion monitoring was per-
formed for the [M-57] fragments for alanine (ALA,
m/z 260), aspartate (ASP, m/z 418), lysine (LYS, m/z
431), and diaminopimelate (DAP, m/z 589), for the
[M-85] fragment of alanine (m/z 232), and for the
[M-159] fragment of aspartate (m/z 316), and lysine
(m/z 329) (see also Additional file 1).
Quantification of the flux-split ratio of the branched
L-lysine pathway
The labeling data from GC-MS analysis were corrected
for the natural isotopes [91] and used to calculate the
molar 13C enrichment (ME) of the analyzed sample [92].
Related to the fragmentation pattern obtained by
electron impact ionization of TBDMS-derivatized amino
acid [92], the 13C enrichment of the C1-carbon in
pyruvate (PYR), oxaloacetate (OAA), and LYS could be
calculated from the [M-57] fragment, and the [M-85]
fragment of alanine, and [M-159] fragment of ASP and
LYS, respectively (Equations 1 – 3). Thirteen-C enrich-
ment of DAP C7 was calculated from the [M-57]
fragment of DAP and LYS, respectively (Equation 4).
Further details are given in Additional file 1.
MEPYR C1 ¼ MEALA260−MEALA232 ð1Þ
MEOAA C1 ¼ MEASP418−MEASP316 ð2Þ
MELYS C1 ¼ MELYS431−MELYS329 ð3Þ
MEDAP C7 ¼ MEDAP589−MELYS431 ð4Þ
Considering the carbon transition of the two parallel
biosynthetic pathway branches in C. glutamicum ([63],
Additional file 1), the contribution of the dehydrogenase
branch to the allover L-lysine flux was calculated as
follows (Equations 5, 6):
f DH ¼
MELYS C1−MEDAP C7
MEDAP C7 þMELYS C1−2MEPYR C1 ð5Þ
f DH ¼
MELYS C1−MEDAP C7
2MEOAA C1−MELYS C1−MEDAP C7 ð6Þ
Determination of diaminopimelate dehydrogenase
activity
Preparation of crude cell extracts was carried out by
mechanical cell disruption and removal of cell debris by
centrifugation [86]. The protein content was then deter-
mined by the method of Bradford [93]. Diaminopimelate
dehydrogenase (DDH) activity was measured in the dir-
ection of the DDH-catalyzed oxidation of meso-diamino-
pimelate and concomitant NADPH formation; this
enzyme assay required an alkaline pH of 10.5 [64]. The
final reaction mixture contained 200 mM glycine/NaOH
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diaminopimelate, and 50 μl of crude cell extract. The
change in absorbance of the enzyme assay mixture was
monitored online at 340 nm (Specord 40; Analytik Jena,
Jena, Germany). Negative controls were performed as
previously described [57].
Additional files
Additional file 1: Flux split quantification of lysine pathway.
Additional file 2: Gene_cluster_alignment.
Abbreviations
AcCoA: Acetyl-CoA; ALA: Alanine; AKG: α-ketoglutarate; ASA: L-aspartate-β-
semialdehyde; Asd: L-aspartate-β-semialdehyde dehydrogenase;
Ask: aspartokinase; ASP: Aspartate; CoA: Coenzyme A; DAP: Diaminopimelate;
DDH: Diaminopimelate dehydrogenase; Ect: Ectoine; EctA: 2,4-diaminobutyrate
acetyltransferase; EctB: L-2,4-diaminobutyrate transaminase; EctC: Ectoine
synthase; EctD: Ectoine hydroxylase; EctOH: Hydroxyectoine; fDH: Relative
flux through DDH; Glu: Glutamate; KanR: kanamycin resistance; LYS: Lysine;
LysE: Lysine exporter; MCS: Multiple cloning site; ME: Molar enrichment;
OAA: Oxaloacetate; ORI: Origin of replication; PCR: Polymerase chain reaction;
PYR: Pyruvate; sacB: Encoding gene of levansucrase from Bacillus subtilis;
Suc: Succinate; TBDMS: Tertbutyl-dimethyl-silyl; Tre: Trehalose; Tuf: Elongation
factor tu.
Competing interests
The authors declare no competing interests.
Authors’ contribution
NS and NSB performed genetic engineering of the ECT-1 strain. NSB
conducted cultivation experiments with ECT-1 in shake flasks and at
miniaturized scale. BJH constructed the ECT-2 strain. BJH and RS performed
shake flask cultivations with ECT-2. RS, BJH and MK carried out fed-batch
fermentation and metabolite studies. JB conducted labeling experiments.
JB and RS designed experiments. JB, EB and CW conceived and structured the
work, assessed the data and wrote the manuscript. All authors read and
approved the manuscript.
Acknowledgements
We appreciate the expert help of Vickie Koogle in the language editing of
our manuscript. E.B. thanks Tom Silhavy for his hospitality and kind support
during a sabbatical at the Department of Molecular Biology of Princeton
University (USA).
Financial support for this study was provided by grants from the LOEWE
program of the state of Hessen (via the Centre for Synthetic Microbiology,
SYNMIRKO; Marburg) (to E.B), the Deutsche Forschungsgemeinschaft (DFG)
through the SFB 987 (to E.B.), and the Fonds der Chemischen Industrie (to E.
B). We further acknowledge the financial support from the BMBF-Grants
“Biobased Polyamides through Fermentation” (No. 0315239A) (to J.B. & C.W.)
and “Systems biology of Microorganisms 2” as part of the research consor-
tium BaCell-SysMO2 (No. 0315784 F) (to J.B., M.K. & C.W.), and the DFG within
the framework of the “Transregio-Sonderforschungsbereich Roseobacter –
SFB/TRR51” (to J.B. & C.W.) and the framework of the Collaborative Research
Center “SFB578 – from Gene to Product” (to C.W.).
Submitted for publication in Microbial Cell Factories.
Author details
1Institute of Biochemical Engineering, Technische Universität Braunschweig,
Braunschweig, Germany. 2Department of Biology, Laboratory for
Microbiology, Philipps-University Marburg, Marburg, Germany.
3LOEWE-Center for Synthetic Microbiology, Philipps-University Marburg,
Marburg, Germany.
Received: 6 August 2013 Accepted: 5 November 2013
Published: 15 November 2013References
1. Wood JM, Bremer E, Csonka LN, Kraemer R, Poolman B, van der Heide T,
Smith LT: Osmosensing and osmoregulatory compatible solute
accumulation by bacteria. Comp Biochem Physiol A Mol Integr Physiol 2001,
130:437–460.
2. Kempf B, Bremer E: Uptake and synthesis of compatible solutes as
microbial stress responses to high-osmolality environments. Arch
Microbiol 1998, 170:319–330.
3. Bremer E, Krämer R: Coping with osmotic challenges: osmoregulation
through accumulation and release of compatible solutes. In Bacterial
Stress Responses. Edited by Storz G, Hengge-Aronis R. Washington D.C.:
ASM Press; 2000:79–97.
4. Diamant S, Eliahu N, Rosenthal D, Goloubinoff P: Chemical chaperones
regulate molecular chaperones in vitro and in cells under combined salt
and heat stresses. J Biol Chem 2001, 276:39586–39591.
5. Chattopadhyay MK, Kern R, Mistou MY, Dandekar AM, Uratsu SL, Richarme
G: The chemical chaperone proline relieves the thermosensitivity of a
dnaK deletion mutant at 42 degrees C. J Bacteriol 2004, 186:8149–8152.
6. Yancey PH: Compatible and counteracting solutes: protecting cells from
the Dead Sea to the deep sea. Sci Prog 2004, 87:1–24.
7. Lentzen G, Schwarz T: Extremolytes: natural compounds from
extremophiles for versatile applications. Appl Microbiol Biotechnol 2006,
72:623–634.
8. Schwibbert K, Marin-Sanguino A, Bagyan I, Heidrich G, Lentzen G, Seitz H,
Rampp M, Schuster SC, Klenk H-P, Pfeiffer F, et al: A blueprint of ectoine
metabolism from the genome of the industrial producer Halomonas
elongata DSM 2581(T). Environ Microbiol 2011, 13:1973–1994.
9. Ignatova Z, Gierasch LM: Inhibition of protein aggregation in vitro and
in vivo by a natural osmoprotectant. Proc Natl Acad Sci USA 2006,
103:13357–13361.
10. Street TO, Bolen DW, Rose GD: A molecular mechanism for osmolyte-induced
protein stability. Proc Natl Acad Sci U S A 2006, 103:13997–14002.
11. Street TO, Krukenberg KA, Rosgen J, Bolen DW, Agard DA: Osmolyte-induced
conformational changes in the Hsp90 molecular chaperone. Protein Sci
2010, 19:57–65.
12. Yancey PH: Organic osmolytes as compatible, metabolic and
counteracting cytoprotectants in high osmolarity and other stresses.
J Exp Biol 2005, 208:2819–2830.
13. Pastor JM, Salvador M, Argandona M, Bernal V, Reina-Bueno M, Csonka LN,
Iborra JL, Vargas C, Nieto JJ, Canovas M: Ectoines in cell stress protection:
uses and biotechnological production. Biotechnol Adv 2010, 28:782–801.
14. Graf R, Anzali S, Buenger J, Pfluecker F, Driller H: The multifunctional role of
ectoine as a natural cell protectant. Clin Dermatol 2008, 26:326–333.
15. Barth S, Huhn M, Matthey B, Klimka A, Galinski EA, Engert A:
Compatible-solute-supported periplasmic expression of functional
recombinant proteins under stress conditions. Appl Environ Microbiol
2000, 66:1572–1579.
16. Schnoor M, Voss P, Cullen P, Boking T, Galla HJ, Galinski EA, Lorkowski S:
Characterization of the synthetic compatible solute homoectoine
as a potent PCR enhancer. Biochem Biophys Res Commun 2004,
322:867–872.
17. Sydlik U, Gallitz I, Albrecht C, Abel J, Krutmann J, Unfried K: The compatible
solute ectoine protects against nanoparticle-induced neutrophilic lung
inflammation. Am J Respir Crit Care Med 2009, 180:29–35.
18. Abdel-Aziz H, Wadie W, Abdallah DM, Lentzen G, Khayyal MT: Novel
effects of ectoine, a bacteria-derived natural tetrahydropyrimidine, in
experimental colitis. Phytomedicine 2013, 20:585–591.
19. Wei L, Wedeking A, Buttner R, Kalff JC, Tolba RH, van Echten-Deckert G: A
natural tetrahydropyrimidine protects small bowel from cold ischemia
and subsequent warm in vitro reperfusion injury. Pathobiology 2009,
76:212–220.
20. Sauer T, Galinski EA: Bacterial milking: A novel bioprocess for production
of compatible solutes. Biotechnol Bioeng 1998, 57:306–313.
21. Lo CC, Bonner CA, Xie G, D'Souza M, Jensen RA: Cohesion group approach
for evolutionary analysis of aspartokinase, an enzyme that feeds a
branched network of many biochemical pathways. Microbiol Mol Biol Rev
2009, 73:594–651.
22. Ono H, Sawada K, Khunajakr N, Tao T, Yamamoto M, Hiramoto M, Shinmyo
A, Takano M, Murooka Y: Characterization of biosynthetic enzymes for
ectoine as a compatible solute in a moderately halophilic eubacterium,
Halomonas elongata. J Bacteriol 1999, 181:91–99.
Becker et al. Microbial Cell Factories 2013, 12:110 Page 14 of 15
http://www.microbialcellfactories.com/content/12/1/11023. Louis P, Galinski EA: Characterization of genes for the biosynthesis of
the compatible solute ectoine from Marinococcus halophilus and
osmoregulated expression in Escherichia coli. Microbiology 1997,
143:1141–1149.
24. Bursy J, Kuhlmann AU, Pittelkow M, Hartmann H, Jebbar M, Pierik AJ,
Bremer E: Synthesis and uptake of the compatible solutes ectoine and
5-hydroxyectoine by Streptomyces coelicolor A3(2) in response to salt
and heat stresses. Appl Environ Microbiol 2008, 74:7286–7296.
25. Reuter K, Pittelkow M, Bursy J, Heine A, Craan T, Bremer E: Synthesis of
5-hydroxyectoine from ectoine: crystal structure of the non-heme
iron(II) and 2-oxoglutarate-dependent dioxygenase EctD. PLoS One 2010,
5:e10647.
26. Kuhlmann AU, Bremer E: Osmotically regulated synthesis of the
compatible solute ectoine in Bacillus pasteurii and related Bacillus spp.
Appl Environ Microbiol 2002, 68:772–783.
27. Kuhlmann AU, Bursy J, Gimpel S, Hoffmann T, Bremer E: Synthesis of the
compatible solute ectoine in Virgibacillus pantothenticus is triggered by
high salinity and low growth temperature. Appl Environ Microbiol 2008,
74:4560–4563.
28. Reshetnikov AS, Khmelenina VN, Trotsenko YA: Characterization of
the ectoine biosynthesis genes of haloalkalotolerant obligate
methanotroph Methylomicrobium alcaliphilum 20Z. Arch Microbiol
2006, 184:286–297.
29. Garcia-Estepa R, Argandona M, Reina-Bueno M, Capote N, Iglesias-Guerra F,
Nieto JJ, Vargas C: The ectD gene, which is involved in the synthesis of
the compatible solute hydroxyectoine, is essential for thermoprotection
of the halophilic bacterium Chromohalobacter salexigens. J Bacteriol 2006,
188:3774–3784.
30. Prabhu J, Schauwecker F, Grammel N, Keller U, Bernhardt M: Functional
expression of the ectoine hydroxylase gene (thpD) from Streptomyces
chrysomallus in Halomonas elongata. Appl Environ Microbiol 2004,
70:3130–3132.
31. Calderon MI, Vargas C, Rojo F, Iglesias-Guerra F, Csonka LN, Ventosa A, Nieto
JJ: Complex regulation of the synthesis of the compatible solute ectoine
in the halophilic bacterium Chromohalobacter salexigens DSM 3043T.
Microbiology 2004, 150:3051–3063.
32. Bestvater T, Louis P, Galinski EA: Heterologous ectoine production in
Escherichia coli: by-passing the metabolic bottle-neck. Saline Systems
2008, 4:12.
33. Stöveken N, Pittelkow M, Sinner T, Jensen RA, Heider J, Bremer E:
A specialized aspartokinase enhances the biosynthesis of the
osmoprotectants ectoine and hydroxyectoine in Pseudomonas stutzeri
A1501. J Bacteriol 2011, 193:4456–4468.
34. Booth IR, Blount P: The MscS and MscL families of mechanosensitive
channels act as microbial emergency release valves. J Bacteriol 2012,
194:4802–4809.
35. Haswell ES, Phillips R, Rees DC: Mechanosensitive channels: what can they
do and how do they do it? Structure 2011, 19:1356–1369.
36. Grammann K, Volke A, Kunte HJ: New type of osmoregulated solute
transporter identified in halophilic members of the bacteria domain:
TRAP transporter TeaABC mediates uptake of ectoine and
hydroxyectoine in Halomonas elongata DSM 2581(T). J Bacteriol 2002,
184:3078–3085.
37. Seip B, Galinski EA, Kurz M: Natural and engineered hydroxyectoine
production based on the Pseudomonas stutzeri ectABCD-ask gene cluster.
Appl Environ Microbiol 2011, 77:1368–1374.
38. Van-Thuoc D, Guzmán H, Quillaguamán J, Hatti-Kaul R: High productivity of
ectoines by Halomonas boliviensis using a combined two-step fed-batch
culture and milking process. J Biotechnol 2010, 147:46–51.
39. Lang YJ, Bai L, Ren YN, Zhang LH, Nagata S: Production of ectoine through
a combined process that uses both growing and resting cells of
Halomonas salina DSM 5928T. Extremophiles 2011, 15:303–310.
40. Schiraldi C, Maresca C, Catapano A, Galinski EA, De Rosa M: High-yield
cultivation of Marinococcus M52 for production and recovery of
hydroxyectoine. Res Microbiol 2006, 157:693–699.
41. Fallet C, Rohe P, Franco-Lara E: Process optimization of the integrated
synthesis and secretion of ectoine and hydroxyectoine under hyper/
hypo-osmotic stress. Biotechnol Bioeng 2010, 107:124–133.
42. Bergmann S, David F, Clark W, Wittmann C, Krull R: Membrane fluidity of
halophilic ectoine-secreting bacteria related to osmotic and thermal
treatment. Bioprocess Biosyst Eng 2013. in press.43. Schubert T, Maskow T, Benndorf D, Harms H, Breuer U: Continuous
synthesis and excretion of the compatible solute ectoine by a
transgenic, nonhalophilic bacterium. Appl Environ Microbiol 2007,
73:3343–3347.
44. Rodriguez-Moya J, Argandona M, Iglesias-Guerra F, Nieto JJ, Vargas C:
Temperature- and salinity-decoupled overproduction of hydroxyectoine
by Chromohalobacter salexigens. Appl Environ Microbiol 2013,
79:1018–1023.
45. Eilert E, Kranz A, Hollenberg CP, Piontek M, Suckow M: Synthesis and
release of the bacterial compatible solute 5-hydroxyectoine in
Hansenula polymorpha. J Biotechnol 2013. in press.
46. Becker J, Wittmann C: Bio-based production of chemicals, materials and
fuels -Corynebacterium glutamicum as versatile cell factory. Curr Opin
Biotechnol 2012, 23:631–640.
47. Becker J, Kind S, Wittmann C: Systems metabolic engineering of
Corynebacterium glutamicum for biobased production of Chemicals,
Materials and Fuels. In Systems Metabolic Engineering. 1st edition. Edited by
Lee SY, Wittmann C. Heidelberg: Springer Verlag; 2012:151–191.
48. Wendisch VF, Polen T: Transcriptome/Proteome analysis of
Corynebacterium glutamicum. In Corynebacterium glutamicum: Biology and
Biotechnology. 1st edition. Edited by Yukawa H, Masayuki I. Berlin: Springer;
2012:173–216 [Steinbüchel A (Series Editor): Microbiol Monogr].
49. Wendisch VF, Bott M, Kalinowski J, Oldiges M, Wiechert W: Emerging
Corynebacterium glutamicum systems biology. J Biotechnol 2006,
124:74–92.
50. Suzuki N, Inui M: Genome Engineering of Corynebacterium glutamicum. In
Corynebacterium glutamicum: Biology and Biotechnology. 1st edition. Edited
by Yukawa H, Masayuki I. Berlin: Springer; 2012:89–106. Microbiol Monogr].
51. Wittmann C, Becker J: The L-lysine story: From metabolic pathways to
industrial production. In Amino acid biosynthesis - Pathways, regulation and
metabolic engineering. 5th edition. Edited by Wendisch VF. Heidelberg:
Springer Berlin/ Heidelberg; 2007:39–70 [Steinbüchel A (Series Editor):
Microbiol Monogr].
52. Varela C, Agosin E, Baez M, Klapa M, Stephanopoulos G: Metabolic flux
redistribution in Corynebacterium glutamicum in response to osmotic
stress. Appl Microbiol Biotechnol 2003, 60:547–555.
53. Becker J, Zelder O, Haefner S, Schröder H, Wittmann C: From zero to
hero–design-based systems metabolic engineering of Corynebacterium
glutamicum for L-lysine production. Metab Eng 2011, 13:159–168.
54. Kalinowski J, Cremer J, Bachmann B, Eggeling L, Sahm H, Pühler A: Genetic
and biochemical analysis of the aspartokinase from Corynebacterium
glutamicum. Mol Microbiol 1991, 5:1197–1204.
55. Schrumpf B, Schwarzer A, Kalinowski J, Pühler A, Eggeling L, Sahm H: A
functionally split pathway for lysine synthesis in Corynebacterium
glutamicum. J Bacteriol 1991, 173:4510–4516.
56. Yan Y, Yang J, Dou Y, Chen M, Ping S, Peng J, Lu W, Zhang W, Yao Z, Li H,
et al: Nitrogen fixation island and rhizosphere competence traits in the
genome of root-associated Pseudomonas stutzeri A1501. Proc Natl Acad
Sci USA 2008, 105:7564–7569.
57. Becker J, Klopprogge C, Zelder O, Heinzle E, Wittmann C: Amplified
expression of fructose 1,6-bisphosphatase in Corynebacterium
glutamicum increases in vivo flux through the pentose phosphate
pathway and lysine production on different carbon sources. Appl Environ
Microbiol 2005, 71:8587–8596.
58. Vrljic M, Garg J, Bellmann A, Wachi S, Freudl R, Malecki MJ, Sahm H, Kozina
VJ, Eggeling L, Saier MH: The LysE superfamily: topology of the lysine
exporter LysE of Corynebacterium glutamicum, a paradyme for a novel
superfamily of transmembrane solute translocators. J Mol Microbiol
Biotechnol 1999, 1:327–336.
59. Wendisch VF, Bott M, Eikmanns BJ: Metabolic engineering of Escherichia
coli and Corynebacterium glutamicum for biotechnological production of
organic acids and amino acids. Curr Opin Microbiol 2006, 9:268–274.
60. Buschke N, Schäfer R, Becker J, Wittmann C: Metabolic engineering of
industrial platform microorganisms for biorefinery applications -
Optimization of substrate spectrum and process robustness by rational
and evolutive strategies. Biores Technol 2013, 135:544–554.
61. Kalinowski J, Bathe B, Bartels D, Bischoff N, Bott M, Burkovski A, Dusch N,
Eggeling L, Eikmanns BJ, Gaigalat L, et al: The complete Corynebacterium
glutamicum ATCC 13032 genome sequence and its impact on the
production of L-aspartate-derived amino acids and vitamins. J Biotechnol
2003, 104:5–25.
Becker et al. Microbial Cell Factories 2013, 12:110 Page 15 of 15
http://www.microbialcellfactories.com/content/12/1/11062. Kind S, Jeong WK, Schröder H, Wittmann C: Systems-wide metabolic
pathway engineering in Corynebacterium glutamicum for bio-based
production of diaminopentane. Metab Eng 2010, 12:341–351.
63. Sonntag K, Eggeling L, De Graaf AA, Sahm H: Flux partitioning in the split
pathway of lysine synthesis in Corynebacterium glutamicum.
Quantification by 13C- and 1H-NMR spectroscopy. Eur J Biochem 1993,
213:1325–1331.
64. Cremer J, Treptow C, Eggeling L, Sahm H: Regulation of enzymes of lysine
biosynthesis in Corynebacterium glutamicum. J Gen Microbiol 1988,
134:3221–3229.
65. Kind S, Kreye S, Wittmann C: Metabolic engineering of cellular transport
for overproduction of the platform chemical 1,5-diaminopentane in
Corynebacterium glutamicum. Metab Eng 2011, 13:617–627.
66. Okino S, Inui M, Yukawa H: Production of organic acids by
Corynebacterium glutamicum under oxygen deprivation. Appl Microbiol
Biotechnol 2005, 68:475–480.
67. Lee SJ, Song H, Lee SY: Genome-based metabolic engineering of
Mannheimia succiniciproducens for succinic acid production. Appl Environ
Microbiol 2006, 72:1939–1948.
68. Buschke N, Becker J, Schäfer R, Kiefer P, Biedendieck R, Wittmann C:
Systems metabolic engineering of xylose-utilizing Corynebacterium
glutamicum for production of 1,5-diaminopentane. Biotechnol J 2013,
8:557–570.
69. Ikeda M: Amino acid production processes. Adv Biochem Eng Biotechnol
2003, 79:1–35.
70. Becker M, Börngen K, Nomura T, Battle AR, Marin K, Martinac B, Krämer R:
Glutamate efflux mediated by Corynebacterium glutamicum MscCG,
Escherichia coli MscS, and their derivatives. Biochem Biophys acta 1828,
2013:1230–1240.
71. Burkovski A, Krämer R: Bacterial amino acid transport proteins:
occurrence, functions, and significance for biotechnological applications.
Appl Microbiol Biotechnol 2002, 58:265–274.
72. Becker J, Wittmann C: Systems and synthetic metabolic engineering for
amino acid production - the heartbeat of industrial strain development.
Curr Opini Biotechnol 2012, 23:718–726.
73. Ikeda M, Takeno S: Amino acid production by Corynebacterium
glutamicum. In Corynebacterium glutamicum: Biology and Biotechnology.
1st edition. Edited by Yukawa H, Masayuki I. Berlin: Springer; 2012:107–148
[Steinbüchel A (Series Editor): Microbiol Monogr].
74. Weinand M, Krämer R, Morbach S: Characterization of compatible solute
transporter multiplicity in Corynebacterium glutamicum. Appl Microbiol
Biotechnol 2007, 76:701–708.
75. Welsh DT: Ecological significance of compatible solute accumulation by
micro-organisms: from single cells to global climate. FEMS Microbiol Rev
2000, 24:263–290.
76. Hoffmann T, Blohn C, Stanek A, Moses S, Barzantny H, Bremer E:
Synthesis, release, and recapture of compatible solute proline by
osmotically stressed Bacillus subtilis cells. Appl Environ Microbiol 2012,
78:5753–5762.
77. Hagemann M, Richter S, Mikkat S: The ggtA gene encodes a subunit of the
transport system for the osmoprotective compound glucosylglycerol in
Synechocystis sp. strain PCC 6803. J Bacteriol 1997, 179:714–720.
78. Ikeda M, Katsumata R: Tryptophan production by transport mutants of
Corynebacterium glutamicum. Biosc Biotech Biochem 1995, 59:1600–1602.
79. Ikeda M, Katsumata R: Transport of aromatic amino acids and its
influence on overproduction of the amino acids in Corynebacterium
glutamicum. J Fermentation Bioeng 1994, 78:420–425.
80. Hermann T: Industrial production of amino acids by coryneform bacteria.
J Biotechnol 2003, 104:155–172.
81. Becker J, Wittmann C: Pathways at Work - Metabolic Flux Analysis of the
Industrial Cell Factory Corynebacterium glutamicum. In Corynebacterium
glutamicum: Biology and Biotechnology. 1st edition. Edited by Yukawa H,
Masayuki I. Berlin: Springer; 2012:217–238 [Steinbüchel A (Series Editor):
Microbiol Monogr].
82. Tauch A, Pühler A, Kalinowski J, Thierbach G: Plasmids in Corynebacterium
glutamicum and their molecular classification by comparative genomics.
J Biotechnol 2003, 104:27–40.
83. Kind S, Jeong WK, Schröder H, Zelder O, Wittmann C: Identification and
elimination of the competing N-acetyldiaminopentane pathway for
improved production of diaminopentane by Corynebacterium
glutamicum. Appl Environ Microbiol 2010, 76:5175–5180.84. Becker J, Buschke N, Bücker R, Wittmann C: Systems Level Engineering of
Corynebacterium glutamicum - Reprogramming Translational Efficiency
for Superior Production. Eng Life Sci 2010, 10:430–438.
85. Kim HM, Heinzle E, Wittmann C: Deregulation of aspartokinase by single
nucleotide exchange leads to global flux rearrangement in the central
metabolism of Corynebacterium glutamicum. J Microbiol Biotechnol 2006,
16:1174–1179.
86. Buschke N, Schröder H, Wittmann C: Metabolic engineering of
Corynebacterium glutamicum for production of 1,5-diaminopentane from
hemicellulose. Biotechnol J 2011, 6:306–317.
87. Mimitsuka T, Sawai H, Hatsu M, Yamada K: Metabolic engineering of
Corynebacterium glutamicum for cadaverine fermentation. Biosci
Biotechnol Biochem 2007, 71:2130–2135.
88. Bolten CJ, Kiefer P, Letisse F, Portais J-C, Wittmann C: Sampling for
metabolome analysis of microorganisms. Anal Chem 2007, 79:3843–3849.
89. Becker J, Klopprogge C, Schröder H, Wittmann C: Metabolic engineering of
the tricarboxylic acid cycle for improved lysine production by
Corynebacterium glutamicum. Appl Environ Microbiol 2009, 75:7866–7869.
90. Kiefer P, Heinzle E, Zelder O, Wittmann C: Comparative metabolic flux
analysis of lysine-producing Corynebacterium glutamicum cultured on
glucose or fructose. Appl Environ Microbiol 2004, 70:229–239.
91. van Winden WA, Wittmann C, Heinzle E, Heijnen JJ: Correcting mass
isotopomer distributions for naturally occurring isotopes. Biotechnol
Bioeng 2002, 80:477–479.
92. Wittmann C: Fluxome analysis using GC-MS. Microb Cell Fact 2007, 6:6.
93. Bradford MM: A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-dye
binding. Anal Biochem 1976, 72:248–254.
doi:10.1186/1475-2859-12-110
Cite this article as: Becker et al.: Systems metabolic engineering of
Corynebacterium glutamicum for production of the chemical chaperone
ectoine. Microbial Cell Factories 2013 12:110.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
